Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

H3 Pharma submits Sanvar IR NDA

March 4, 2004

Enrollment complete in phase IV Visicol constipation study

March 3, 2004

Enzo Biochem acquires OraGen

March 2, 2004

Merck and Isis scientists present new NS5B inhibitors for HCV infection

Feb. 27, 2004

Serono receives rights to InDex's Kappaproct

Feb. 27, 2004

Phase I program commences for HCV-086

Feb. 26, 2004

Entereg receives fast track status for postoperative ileus

Feb. 26, 2004

Nabi reports preliminary results from phase I/II Cicavir study

Feb. 25, 2004

Oral rhIL-11 improves mucosal inflammation in chronic colitis model

Feb. 25, 2004

Preliminary efficacy results of a Zadaxin triple therapy in hepatitis C

Feb. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...